Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pleural fluid metabolite combination, kit and method for diagnosing tuberculous pleurisy

A tuberculous pleurisy and kit technology, applied in the field of kits and pleural effusion metabolite combinations for the diagnosis of tuberculous pleurisy, can solve the problems of difficult identification, missed or misdiagnosed, and low sensitivity between tumor cells and inflammatory mesothelial cells

Active Publication Date: 2021-04-30
XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, the methods for clinical diagnosis and identification of tuberculous pleurisy and malignant pleurisy include clinical manifestations, thoracentesis test results, pleural biopsy, bronchoscopy, surgical biopsy, etc. The most commonly used method is thoracentesis for cytological examination. Tumor cells found in pleural effusion have diagnostic value for malignant pleurisy, but due to the complex cell components in pleural effusion, it is sometimes difficult to distinguish tumor cells from inflammatory mesothelial cells, macrophages, etc. Influenced by other factors, its sensitivity is low (about 40%-60%), and the disadvantages of strong subjectivity are likely to cause missed diagnosis or misdiagnosis; while the diagnosis of tuberculous pleurisy mainly includes pleural effusion biochemical examination, tuberculin skin test ( TST), pleural effusion bacteriological examination (acid-fast stained smear and Mycobacterium tuberculosis culture), pleural histopathological biopsy, etc.
However, the specificity and sensitivity of the above-mentioned inspection methods are low, and some methods are invasive, high-risk, or have a long time period, which cannot meet the needs of clinical work. Therefore, the development of new and highly sensitive diagnostic techniques for pleurisy has very important clinical significance.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pleural fluid metabolite combination, kit and method for diagnosing tuberculous pleurisy
  • Pleural fluid metabolite combination, kit and method for diagnosing tuberculous pleurisy
  • Pleural fluid metabolite combination, kit and method for diagnosing tuberculous pleurisy

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] 1. Before the collection of pleural fluid samples, the included volunteers signed the informed consent.

[0038] Inclusion criteria for tuberculous pleurisy: clinical manifestations of tuberculous pleurisy: low fever, night sweats, fatigue, chest tightness, exudative pleural effusion, etc.; at the same time, pleural effusion and / or sputum culture positive for Mycobacterium tuberculosis, and / or pleural Histopathological examination was positive for tuberculosis; and the follow-up anti-tuberculosis treatment was effective, diagnosed as tuberculous pleurisy patients.

[0039] Inclusion criteria for the malignant pleurisy group: exudative pleural effusion, tumor cells found in exfoliated cells of pleural effusion; and / or pleural histopathological examination clearly showed tumor pleural metastasis.

[0040]Under the same conditions, pleural effusion samples were used: pleural effusion samples from 10 cases of malignant pleurisy and 10 cases of tuberculous pleurisy; 50ml of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The present invention relates to a pleural effusion metabolite combination, a kit and a method for diagnosing tuberculous pleurisy, the pleural effusion metabolite combination for diagnosing tuberculous pleurisy comprising dimethylglycine, tyrosine, kynurenine, and nicotinamide , betaine, acylcarnitine 12:0, acylcarnitine 14:2 and phosphatidylcholine 42:8. Kit for the diagnosis of tuberculous pleurisy, including for the detection of dimethylglycine, tyrosine, kynurenine, nicotinamide, betaine, acylcarnitine 12:0, acylcarnitine 14 in the extraction solution of pleural fluid samples :2 and Phosphatidylcholine 42:8 are the required internal standards. Through the combined markers involved in the present invention, the diagnosis of tuberculous pleurisy can be characterized with high sensitivity and high specificity. At the same time, the combined marker can be complementary to the traditional marker adenosine deaminase, and combined use can be used for auxiliary diagnosis of tuberculous pleurisy.

Description

technical field [0001] The invention relates to a diagnosis method for tuberculous pleurisy, in particular to a combination of pleural effusion metabolites, a kit and a method for diagnosing tuberculous pleurisy. Background technique [0002] Tuberculous pleurisy is a common clinical extrapulmonary tuberculosis with a relatively high incidence, accounting for about 44.1% of the total pleural diseases. In my country, the incidence of malignant pleurisy is as high as 900,000 per year, accounting for about 9% of the world's total. The morbidity and mortality rate of lung cancer is one of the highest tumors in the world, and about 40% of lung cancer patients will have malignant pleural effusion during the disease process. At present, due to the limitations of diagnostic techniques, the proportion of confirmed cases is very low. However, the prognosis and treatment of tuberculous pleurisy and malignant pleurisy are completely different. If not diagnosed and treated in time, it w...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G01N30/02G01N30/06G01N30/30G01N30/32G01N30/34G01N30/72
CPCG01N30/02G01N30/06G01N30/30G01N30/32G01N30/34G01N30/72G01N2030/324
Inventor 金阳罗萍毛开敏许娟娟黄琪
Owner XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products